RS56559B1 - Use of p3 of bacteriophage fusion proteins as amyloid binding agents - Google Patents
Use of p3 of bacteriophage fusion proteins as amyloid binding agentsInfo
- Publication number
- RS56559B1 RS56559B1 RS20170941A RSP20170941A RS56559B1 RS 56559 B1 RS56559 B1 RS 56559B1 RS 20170941 A RS20170941 A RS 20170941A RS P20170941 A RSP20170941 A RS P20170941A RS 56559 B1 RS56559 B1 RS 56559B1
- Authority
- RS
- Serbia
- Prior art keywords
- fusion proteins
- binding agents
- amyloid binding
- bacteriophage
- bacteriophage fusion
- Prior art date
Links
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261708709P | 2012-10-02 | 2012-10-02 | |
US201261730316P | 2012-11-27 | 2012-11-27 | |
US201361801349P | 2013-03-15 | 2013-03-15 | |
US201361828105P | 2013-05-28 | 2013-05-28 | |
EP13776674.7A EP2906235B1 (en) | 2012-10-02 | 2013-10-01 | Use of p3 of bacteriophage fusion proteins as amyloid binding agents |
PCT/US2013/062862 WO2014055515A1 (en) | 2012-10-02 | 2013-10-01 | Use of p3 of bacteriophage fusion proteins as amyloid binding agents |
Publications (1)
Publication Number | Publication Date |
---|---|
RS56559B1 true RS56559B1 (en) | 2018-02-28 |
Family
ID=61257143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20170941A RS56559B1 (en) | 2012-10-02 | 2013-10-01 | Use of p3 of bacteriophage fusion proteins as amyloid binding agents |
Country Status (2)
Country | Link |
---|---|
ME (1) | ME02851B (en) |
RS (1) | RS56559B1 (en) |
-
2013
- 2013-10-01 ME MEP-2017-215A patent/ME02851B/en unknown
- 2013-10-01 RS RS20170941A patent/RS56559B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ME02851B (en) | 2018-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1213775A1 (en) | Use of p3 of bacteriophage fusion proteins as amyloid binding agents p3 | |
HK1216538A1 (en) | Human anti-tau antibodies | |
HK1192587A1 (en) | Therapeutic fusion proteins | |
EP2877854A4 (en) | Fusion proteins and methods thereof | |
EP2929045A4 (en) | Protein expression enhancing polypeptides | |
HK1213521A1 (en) | Methods of using fix polypeptides fix | |
HK1216159A1 (en) | Therapeutic fusion protein | |
EP2782589A4 (en) | Anti-microbial peptides and methods of use thereof | |
SG10201709849TA (en) | Use of p3 of bacteriophage as amyloid binding agents | |
EP2711376A4 (en) | Fgfr-fc fusion protein and use thereof | |
HK1205524A1 (en) | Engineered conformationally-stabilized proteins | |
EP2683742A4 (en) | Npp1 fusion proteins | |
EP2930189A4 (en) | Chemokine-cytokine fusion protein and application thereof | |
HK1204948A1 (en) | Radiation-sterilization-resistant protein composition | |
EP2922871A4 (en) | Methods and compositions for modified factor ix proteins | |
EP3560952C0 (en) | Variant of bpifb4 protein | |
RS56559B1 (en) | Use of p3 of bacteriophage fusion proteins as amyloid binding agents | |
GB201213672D0 (en) | Protein | |
GB201200743D0 (en) | Protein bridges | |
GB201215901D0 (en) | Protein modification | |
EP2817324A4 (en) | Nemo binding domain fusion proteins | |
GB201114701D0 (en) | Fusion proteins | |
GB201107189D0 (en) | Fusion proteins |